MD Anderson to advance cancer prevention, treatment, research and education in Mozambique and Brazil

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The University of Texas MD Anderson Cancer Center plans to expand its global oncology efforts in Mozambique and Brazil, including a new four-year agreement to broaden existing cancer prevention and treatment efforts with the Ministry of Health in Mozambique and a $5.1 million grant from NIH focused on cervical cancer prevention and treatment among women living with the human immunodeficiency virus.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Venkata Lokesh BattulaClinton YamA multidisciplinary team of researchers at VCU Massey Comprehensive Cancer Center and MD Anderson Cancer Center has been awarded a $7.3 million grant from the U.S. Department of Defense to fund a novel clinical trial targeting one of the most aggressive and hard-to-treat forms of breast cancer: metastatic triple-negative breast cancer. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login